NAVIGATION
Drug Discovery & Development Strategy Meeting Tokyo 2017

Proventa International will be gathering over 100 C-Level Directors from a mix of emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve their key strategic challenges in the area of Drug Discovery.

Register Now
2nd October 2017, Tokyo, Japan

AGENDA

The Drug Discovery and Development Round Table Discussion Strategy Meeting Japan is aim to gather Senior Executives of Early Drug Discovery (from medium to large Pharma, Biopharma and Biotech players) as well as thought leaders from Academia and regulatory authorities to exchange ideas and present cutting-edge discoveries, research and new therapeutic drugs and to determine successful R&D and partnering strategies being used by pharmaceutical and biotechnology companies to build their drug pipelines.

​Thought leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:​ ​
​- ​Chemistry, Immunology Chemistry, Chemistry Technologies, Medicinal and Innovative Chemistry, Drug Discovery & DMPK, Chemical and Molecular Therapeutics, Chemical Development, Biochemistry & Molecular Pharmacology, Computational and Structural Chemistry, Biochemistry.

Important: Roundtable discussion will be in Japanese language and Keynote presentation will be in English translated into Japanese.

Drug Discovery & Development Strategy Meeting 2017

DOWNLOAD AGENDA

Testimonials

Medicinal Chemistry Strategy Meeting APAC 2016

BIOINFORMATICS Strategy Meeting APAC 2016

Samuel T. Labrie, VP Corporate Development, Myriad RBM

Kam Dhaliwal, SVP Services & Alliances, Horizon Discovery

Matt Hersch, Clinical Operations Manager, GW Pharmaceuticals

Rainer Metzger, VP Global Business Development Pharma, Qiagen

Dilsaid Babayigit, Founder & CEO, Ageneo

John Apathy, Vice President, R&D informatics, Celgene

Lars Branden, Senor Director,Informatics R&D Division,Retro Screen Virology Ltd.

Dominic Clark , Industry Programme Manager,EMBL-EBI

Yike Guo, Director Data Science Institude, Imperial College London

John Wise, Executive Director, Pistoia Alliance

Abel Ureta-Vida, CEO, Eagle Genomics

Alexander Scheer, Deputy Head of Research, Pierre Fabre

Jerome Wojcik , CEO,Quartz Bio

Oleksandr Otava, Head Of Scientific IT, Affiris AG

Sowmyanarayan Srinivasan, Director R&D Practise,Global Delivery Leader Discovery

Medicinal Chemistry Strategy Meeting APAC 2016,

BIOINFORMATICS Strategy Meeting APAC 2016

Samuel T. Labrie, VP Corporate Development, Myriad RBM

Kam Dhaliwal, SVP Services & Alliances, Horizon Discovery

Matt Hersch, Clinical Operations Manager, GW Pharmaceuticals

Rainer Metzger, VP Global Business Development Pharma, Qiagen

Dilsaid Babayigit, Founder & CEO, Ageneo

John Apathy, Vice President, R&D informatics, Celgene

Lars Branden, Senor Director,Informatics R&D Division,Retro Screen Virology Ltd.

Dominic Clark , Industry Programme Manager,EMBL-EBI

Yike Guo, Director Data Science Institude, Imperial College London

John Wise, Executive Director, Pistoia Alliance

Abel Ureta-Vida, CEO, Eagle Genomics

Alexander Scheer, Deputy Head of Research, Pierre Fabre

Jerome Wojcik , CEO,Quartz Bio

Oleksandr Otava, Head Of Scientific IT, Affiris AG

Sowmyanarayan Srinivasan, Director R&D Practise,Global Delivery Leader Discovery

Past Meetings

Med Chem APAC 2016
Shangri-la Hotel, Singapore
VIEW AGENDA
Bioinformatics APAC 2016
Shangri-la Hotel, Singapore
VIEW AGENDA

Location

Grand Prince Hotel New Takanawa
Tokyo, Japan

Date:Oct 02,2017

Book your seat for the Drug Discovery & Development Strategy Meeting APAC 2017

Register Now